Skip to main content

Table 4 Treatment according to guidelines

From: Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider’s routine data

 

2009

Medical service

Enrolled patients (N = 314)

Non-participating patients (N = 11,885)

P Value

HbA1C measurement - no. (%)

  

<0.001

 

none

40 (12.7)

4,353 (36.6)

 
 

1

232 (73.9)

6,867 (57.8)

 
 

2

42 (13.4)

653 (5.5)

 
 

3

0 (0.0)

15 (0.1)

 
 

4+

0 (0.0)

0 (0.0)

 

Ophtalmoscopy - no. (%)

  

<0.001

 

none

156 (49.7)

7,884 (66.3)

 
 

1+

158 (50.3)

4,004 (33.7)

 

Electrocardiogram - no. (%)

  

<0.001

 

none

155 (49.4)

7,755 (65.2)

 
 

1+

159 (50.6)

4,132 (34.8)

 

Serum lipids - no. (%)

  

<0.001

 

none

45 (14.3)

4,535 (38.1)

 
 

1+

269 (85.7)

7,353 (61.9)

 

Microalbumin - no. (%)

  

<0.001

 

none

206 (65.6)

11,288 (95.0)

 
 

1+

108 (34.4)

599 (5.0)

 

Status of blood vessels - no. (%)

  

<0.001

 

none

203 (64.6)

9,445 (79.4)

 
 

1+

111 (35.4)

2,443 (20.6)

 
  1. All variables were compared with Pearson's chi-square test.